Back to Search Start Over

Cost‐benefit of reimbursement for pharmaceutical care in Taiwan.

Authors :
Wu, Chien‐Chih
Tsai, Shu‐Ling
Ku, Pou‐Jen
Wu, Fe‐Lin Lin
Huang, Li‐Jung
Tseng, Wan‐Yun
Li, I‐Hsun
Wang, Ting‐Ying
Wang, Ming‐Shyan
Kuo, Li‐Na
Chang, Yuh‐Lih
Su, Hui‐Chen
Lin, Yu‐Jing
Cheng, Yih‐Dih
Chen, Chi‐Hua
Huang, Yu‐Chia
Wang, Chi‐Chuan
Shen, Li‐Jiuan
Source :
JACCP: Journal of the American College of Clinical Pharmacy; May2021, Vol. 4 Issue 5, p604-611, 8p
Publication Year :
2021

Abstract

Background: Pharmaceutical care provided by well‐educated clinical pharmacists improves the safety and effectiveness of health care, especially regarding medication use, and can thus save costs. Aims: The aim of this study is to illustrate the implementation of the reimbursement policy of National Health Insurance for pharmaceutical care in Taiwan, to determine its influences on current health care practices, and to evaluate the quantity of pharmacy interventions. Materials & Methods: The inclusion criteria for this study were qualified pharmacists working in intensive care units (ICUs) at medical centers and regional hospitals or in clinics at district hospitals who provided pharmaceutical care services. Details of the pharmaceutical care they provided—including pharmacy notes (in the subjective, objective, assessment, and plan sequence), intervention type, and acceptance by physicians—were uploaded and documented via an online virtual private network platform, from which data were later collected and analyzed. Results: During the first quarter of 2019, a total of 260 pharmacists were included in the analysis, 109 of whom were from medical centers, 94 from regional hospitals, and 57 from district hospitals. The total person‐days of pharmaceutical care during the study period was 12 158 for medical centers, 7090 for regional hospitals, and 757 for district hospitals. The acceptance rates of the doctors were 98.3%, 89.5%, and 90.5% for medical centers, regional hospitals, and district hospitals, respectively. Discussion: The cost savings of pharmaceutical care was estimated by adverse drug events (ADEs) avoidance based on an average prolonged ICU stay of 2 days per ADE. Pharmaceutical care in ICUs resulted in a savings of 57 931 710 New Taiwan Dollars during the study period, with a cost‐benefit ratio of 13.7. Conculsion: Based on the cost effectiveness of pharmaceutical care in early 2019, the program should be reserved and expanded to different settings, and it will hopefully become an essential service provided by pharmacists in Taiwan. [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
MEDICAL care
INTENSIVE care units

Details

Language :
English
ISSN :
25749870
Volume :
4
Issue :
5
Database :
Complementary Index
Journal :
JACCP: Journal of the American College of Clinical Pharmacy
Publication Type :
Academic Journal
Accession number :
150340113
Full Text :
https://doi.org/10.1002/jac5.1404